4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-014545
Chief Executive Officer sold 19,045 shares at $103.69 ($1,974,738)
- Chief Executive Officer acquired 36,413 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Sale : show line 1 in the form | −19,045 | $103.69 | $1,974,738 | 634,493 | D |
| 2026-11-16 | Grant or award : show line 2 in the form | +36,413 | 670,906 | D | ||
| Open-market sales · 19,045 sh · avg $103.69 · $1,974,738 | ||||||
Loading xslF345X06/marketforms-74343.xml…